Centre de recherche
mardi 1 août 2023
Concours de subventions Projets du printemps 2023 des IRSC
5,5M$ pour la recherche en santé mère-enfant au CHU Sainte-Justine!
Les Instituts de recherche en santé du Canada (IRSC) ont annoncé des subventions totalisant 5,49 M$ à huit projets du Centre de recherche du CHU Sainte-Justine, dans le cadre du concours de subventions Projet du printemps 2023.
Toutes nos félicitations aux récipiendaires!
|
Chercheur(-se) principal désigné et autres chercheur(-se)s principaux au CHU Sainte-Justine
|
Co-chercheur(-se)s au CHU Sainte-Justine |
Montant ($) |
Titre du projet de recherche |
| Dr Olivier Drouin* |
-- |
761 175
|
Low-value care and variation in practice in the care of children hospitalized with bronchiolitis in Canada
|
|
Dre Geneviève Du Pont-Thibodeau*; Miriam Beauchamp
|
-- |
948 962 |
Outcomes of Children and Families After Discharge from Pediatric Intensive Care Units
|
|
Dre Anne Gallagher*;
Guillaume Dumas; Miriam Beauchamp
|
Dre Elana Pinchefsky
|
550 800 |
Executive functioning and parent-child relationship in infants with CHD: early screening and underlying brain mechanisms
|
| Dr Sébastien Jacquemont* |
Guillaume Dumas; Dr Tomas Paus |
734 400
|
Combining Space, Time, and cell types to decode and explain the effect sizes of rare genomic variants on cognition and psychopathology.
|
| Dre Thuy Mai Luu* |
Marie-Noelle Simard; Mi-Suk Kang Dufour |
952 426 |
Implementation of best practices for earlier diagnosis of cerebral palsy in very preterm infants: a stepped-wedge cluster randomized controlled trial
|
|
Dre Elana Pinchefsky*; Dre Sophie Tremblay
|
Dre Anne Gallagher |
573 750 |
Integrating early neuromonitoring biomarkers to better define eligibility for therapeutic hypothermia after perinatal hypoxia-ischemia
|
|
Noël J. Raynal*; Houman Savoji
|
-- |
868 276 |
Modelling cell dynamics and epigenetic changes in 3D spheroids with custom-made hydrogels
|
| Annonce de priorité : recherche sur le cancer pédiatrique |
| Dr Michel Duval* |
Dre Sonia Cellot |
100 000 |
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
|